Stockstobuytoday
RITM Rithm Capital Ready for a Breakout!RITM Rithm Capital to release Q4 and full year 2022 financial results for the period ended December 31, 2022 on Wednesday, February 8, 2023 prior to the opening of the New York Stock Exchange!
2.02 EPS
4.363B MARKET CAP
10.86% DIV YIELD!!!
4.73 P/E Ratio!!!
Extremely undervalued in my opinion!
But now comes the best part! You can buy the following options:
2023-2-17 expiration date
$10 strike price
for only $0.05 premium now!
So the expiration date is after the earnings, if the stock goes to $11, and i wouldn`t be surprised if the results are great, then this is a 20X call that you are reading about.
This is a premium call in my opinion, do you research before investing, as you know!
TMC The Metals Company could electrify the entire US EV fleet !TMC holds exploration and commercial rights to three contract areas which host an estimated 1.6 billion tonnes of polymetallic nodules containing high grade nickel, copper , cobalt and manganese, in the Clarion Clipperton Zone of the Pacific Ocean.
The Planet’s Largest Resource of Battery Metals could electrify the entire US electric vehicle fleet.
The Metals Company successfully concluded its $75 million multi-year deep-sea research program to establish the potential impacts of the Company’s proposed polymetallic nodule collection operations.
Market Cap of only 213.756Mil
Insider buys between $1.01 and $4.44!
Now the stock is $0.94.
I consider TMC to be one of the best buys of 2021!
HGEN in EU Commission 10 Most Promising Treatments for COVID-19!European Commission’s independent experts selected Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19!
CEO of Humanigen said today: "We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19".
In the same list you can see Pfizer, Roche, Astra Zeneca and Eli Lilly! Humanigen is the smallest company.
Institutions loaded big on this dip of Humanigen, Inc. (HGEN), 132Mil in the last quarter!
On 8/23/2021 Morgan Stanley reported an increased ownership in HGEN by +1,884.6%!
Biggest shareholder is Blackrock with 3,037,693 shares worth $52.80Mil, which increased its position by +283.5% for a total ownership of 5.141% of Humanigen.
So Blackrock paid an average of 17.3usd per share!
The price of the stock is now 6.60usd!
H.C. Wainwright’s Joseph Pantginis rates HGEN a Buy along with a $28 price target and said the market overreacted on that selloff.
My price target is the 16.3usd resistance!
ACB The return of Cannabis stocksCannabis stocks like Aurora Cannabis, and this is not the most bullish, have been beaten up in the past 6 months, while they kept delivering good results.
Aurora Cannabis Launched its First Medical CBD Product in Uruguay 2 days ago.
The CBD oil is available in 3% and 10% concentrations in pharmacies across the country.
My price target is the 12.6usd resistance.